G. Calais

12.7k total citations · 4 hit papers
179 papers, 8.3k citations indexed

About

G. Calais is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G. Calais has authored 179 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Oncology, 70 papers in Pulmonary and Respiratory Medicine and 69 papers in Surgery. Recurrent topics in G. Calais's work include Head and Neck Cancer Studies (68 papers), Colorectal Cancer Surgical Treatments (29 papers) and Colorectal and Anal Carcinomas (26 papers). G. Calais is often cited by papers focused on Head and Neck Cancer Studies (68 papers), Colorectal Cancer Surgical Treatments (29 papers) and Colorectal and Anal Carcinomas (26 papers). G. Calais collaborates with scholars based in France, Belgium and Serbia. G. Calais's co-authors include É. Bardet, P. Maingon, Jean-François Bosset, Laurent Mineur, Laurence Collette, Ljiljana Radošević-Jelić, Alexander Beny, A. Daban, Jean-Claude Ollier and M. Alfonsi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

G. Calais

172 papers receiving 8.1k citations

Hit Papers

Chemotherapy with Preoperative Radiotherapy in Rectal Cancer 1999 2026 2008 2017 2006 1999 2003 2014 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Calais France 39 5.2k 5.1k 2.7k 2.5k 751 179 8.3k
É. Bardet France 27 4.4k 0.8× 4.3k 0.8× 2.6k 1.0× 2.2k 0.9× 560 0.7× 81 6.7k
Bhadrasain Vikram United States 40 2.2k 0.4× 2.3k 0.4× 2.0k 0.7× 1.6k 0.6× 1.2k 1.6× 148 5.9k
Julie A. Kish United States 33 3.1k 0.6× 3.7k 0.7× 5.2k 1.9× 2.5k 1.0× 322 0.4× 82 7.3k
Muhyi Al‐Sarraf United States 47 4.4k 0.8× 7.1k 1.4× 5.0k 1.8× 6.0k 2.4× 593 0.8× 146 12.2k
Thomas J. Keane Canada 37 1.4k 0.3× 1.8k 0.4× 1.2k 0.5× 1.6k 0.6× 861 1.1× 80 4.3k
Jean-Claude Horiot France 38 2.2k 0.4× 2.6k 0.5× 2.0k 0.7× 2.0k 0.8× 1.4k 1.9× 108 7.1k
F. Cognetti Italy 27 2.3k 0.4× 1.9k 0.4× 2.2k 0.8× 1.3k 0.5× 297 0.4× 129 4.8k
Laura D. Locati Italy 38 2.8k 0.5× 2.9k 0.6× 1.8k 0.7× 1.1k 0.4× 404 0.5× 204 6.0k
Jan B. Vermorken Belgium 35 2.2k 0.4× 2.3k 0.4× 2.1k 0.8× 1.6k 0.6× 190 0.3× 96 5.6k
Kerstin Stenson United States 37 1.9k 0.4× 2.1k 0.4× 2.8k 1.0× 1.8k 0.7× 291 0.4× 133 4.7k

Countries citing papers authored by G. Calais

Since Specialization
Citations

This map shows the geographic impact of G. Calais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Calais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Calais more than expected).

Fields of papers citing papers by G. Calais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Calais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Calais. The network helps show where G. Calais may publish in the future.

Co-authorship network of co-authors of G. Calais

This figure shows the co-authorship network connecting the top 25 collaborators of G. Calais. A scholar is included among the top collaborators of G. Calais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Calais. G. Calais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Guérif, S., R. de Crevoisier, G. Calais, et al.. (2024). Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S4–S5. 1 indexed citations
3.
Pointreau, Y., et al.. (2023). Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity. Cancer/Radiothérapie. 27(3). 225–232. 2 indexed citations
5.
Supiot, S., et al.. (2022). Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients. Frontiers in Oncology. 11. 787347–787347. 4 indexed citations
6.
Müller, Olivier, Nicolas Tabchouri, Driffa Moussata, et al.. (2021). Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma. Anticancer Research. 42(1). 155–164. 2 indexed citations
7.
Pointreau, Y., C. Lafond, P. Trémolières, et al.. (2016). Radiothérapie des cancers du larynx. Cancer/Radiothérapie. 20. S131–S135. 4 indexed citations
8.
Bosset, Jean-François, G. Calais, Laurent Mineur, et al.. (2014). Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. The Lancet Oncology. 15(2). 184–190. 505 indexed citations breakdown →
9.
10.
Isambert, A., Vincent Grégoire, G. Calais, et al.. (2007). Atlas-based automatic segmentation (ABAS) of head and neck (H&N) structures in conformal radiotherapy (CRT): Atlas development and preliminary results in clinical context. Radiotherapy and Oncology. 84. 3 indexed citations
11.
Bardet, É., Laurent Martin, G. Calais, et al.. (2005). Subcutaneous (SbQ) Versus Intravenous (IV) Administration of Amifostine for Head and Neck (HN) Cancer Patients Receiving Radiotherapy (RT): Preliminary Results of the GORTEC 2000–02 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 63. S127–S127. 5 indexed citations
12.
Bensadoun, René‐Jean, Karen Bénézery, A. Ramaioli, et al.. (2004). Phase III multicenter randomized study of concurrent twice-a-day radiotherapy with and without cisplatin-5FU (BiRCF) in unresectable pharyngeal carcinoma. 24 months results (FNCLCC-GORTEC). International Journal of Radiation Oncology*Biology*Physics. 60(1). S161–S161. 1 indexed citations
13.
Bourhis, Jean, G. Calais, M. Lapeyre, et al.. (2004). Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Seminars in Oncology. 31(6). 822–826. 31 indexed citations
14.
Bougnoux, Philippe, Emmanuelle Germain, Véronique Chajès, et al.. (1999). Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. British Journal of Cancer. 79(11-12). 1765–1769. 62 indexed citations
15.
Colombat, Philippe, F Fétissof, G. Calais, et al.. (1990). [Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy].. PubMed. 77(8). 811–20. 1 indexed citations
16.
Goga, D., et al.. (1990). [Epithelioma of the medial canthus. Retrospective study of 47 surgically treated cases].. PubMed. 13(3). 87–91. 1 indexed citations
17.
Calais, G., et al.. (1990). Prognostic factors in the radiotherapeutic conservative management of rectal tumors: Results according to the dijon staging system:. International Journal of Radiation Oncology*Biology*Physics. 19. 178–178. 1 indexed citations
18.
Chauvet, B., et al.. (1989). Radiothérapie après chimiothérapie et deuxième laparotomie dans le traitement des cancers de l'ovaire à un stade avancé.. 32(2). 2 indexed citations
19.
Calais, G., et al.. (1989). [Carcinomas of the base of tongue: analysis of treatment results in 115 patients].. PubMed. 76(4). 395–401. 1 indexed citations
20.
Roth, Stephan, et al.. (1988). Results of Endocavitary Irradiation of Early Rectal Tumors. Acta Oncologica. 27(6). 825–827. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026